Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Chapman

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Journal of Medicinal Chemistry|March 30, 1992
Synthesis and cholinergic properties of bis[[(dimethylamino)methyl]furanyl] analogues of ranitidineJ W Sowell, Y Tang, M J Valli, et al.
Conservation Physiology|May 23, 2020
Handling, infectious agents and physiological condition influence survival and post-release behaviour in migratory adult coho salmon after experimental displacementJ M Chapman, A K Teffer, A L Bass, et al.
Journal of Lipid Research|June 1, 1997
Potent hypocholesterolemic activity of novel ureido phenoxyisobutyrates correlates with their intrinsic fibrate potency and not with their ACAT inhibitory activityR L Hawke, J M Chapman, D A Winegar, et al.
Conservation Physiology|June 14, 2019
Evidence of a hydraulically challenging reach serving as a barrier for the upstream migration of infection-burdened adult steelheadW M Twardek, J M Chapman, K M Miller, et al.
Journal of Virology|August 3, 2007
Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to PolA C Karlsson, J M Chapman, B D Heiken, et al.
Genes and Immunity|March 19, 2004
Cost-effective analysis of candidate genes using htSNPs: a staged approachC E Lowe, J D Cooper, J M Chapman, et al.
Journal of Medicinal Chemistry|October 3, 1999
A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activityP J Brown, D A Winegar, K D Plunket, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Journal of Medicinal Chemistry|March 30, 1992
Synthesis and cholinergic properties of bis[[(dimethylamino)methyl]furanyl] analogues of ranitidineJ W Sowell, Y Tang, M J Valli, et al.
Conservation Physiology|May 23, 2020
Handling, infectious agents and physiological condition influence survival and post-release behaviour in migratory adult coho salmon after experimental displacementJ M Chapman, A K Teffer, A L Bass, et al.
Journal of Lipid Research|June 1, 1997
Potent hypocholesterolemic activity of novel ureido phenoxyisobutyrates correlates with their intrinsic fibrate potency and not with their ACAT inhibitory activityR L Hawke, J M Chapman, D A Winegar, et al.
Conservation Physiology|June 14, 2019
Evidence of a hydraulically challenging reach serving as a barrier for the upstream migration of infection-burdened adult steelheadW M Twardek, J M Chapman, K M Miller, et al.
Journal of Virology|August 3, 2007
Antiretroviral drug therapy alters the profile of human immunodeficiency virus type 1-specific T-cell responses and shifts the immunodominant cytotoxic T-lymphocyte response from Gag to PolA C Karlsson, J M Chapman, B D Heiken, et al.
Genes and Immunity|March 19, 2004
Cost-effective analysis of candidate genes using htSNPs: a staged approachC E Lowe, J D Cooper, J M Chapman, et al.
Journal of Medicinal Chemistry|October 3, 1999
A ureido-thioisobutyric acid (GW9578) is a subtype-selective PPARalpha agonist with potent lipid-lowering activityP J Brown, D A Winegar, K D Plunket, et al.
Pageof 9